Alector Inc (ALEC)
4.995
-0.28
(-5.22%)
USD |
NASDAQ |
Nov 05, 16:00
4.995
0.00 (0.00%)
After-Hours: 18:10
Alector Research and Development Expense (Annual): 192.12M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 192.12M |
| December 31, 2022 | 210.42M |
| December 31, 2021 | 189.41M |
| December 31, 2020 | 156.87M |
| Date | Value |
|---|---|
| December 31, 2019 | 100.53M |
| December 31, 2018 | 73.03M |
| December 31, 2017 | 29.91M |
| December 31, 2016 | 13.67M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
100.53M
Minimum
2019
210.42M
Maximum
2022
169.87M
Average
189.41M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Omeros Corp | 114.87M |
| Nuwellis Inc | 5.422M |
| Harrow Inc | 6.652M |
| Amphastar Pharmaceuticals Inc | 73.74M |
| PetIQ Inc | -- |